CClinicalTrials.gg
CompletedNCT00550186Updated Jun 28, 2016

Effect of Preload on Bladder Retention Volume During Spinal Anesthesia

An interventional study of placebo and Ringers Lactate in Diuresis, Bladder Retention Volume and Hypotension, sponsored by Rijnstate Hospital. Completed at 1 site in Netherlands. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2016-06-28.

Sponsored by Rijnstate Hospital · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to assess the influence of different fluid infusions on the quantity of bladder retention after spinal anesthesia. This study should determine if this increase in bladder retention is significant and relevant.

Read the detailed description

Background of the study:

Spinal anesthesia , through interruption of spinal nerve conduction, causes intense blockade of sensation, motor function as well as (para)sympathetic function. Loss of sympathetic tone causes vasodilation which may lead to arterial hypotension and bradycardia. To avoid these effects, in anesthetic practice, usually intravenouspreload is administered as cristalloids or colloids. The form and dosage of these plasma expanders will influence diuresis during spinal anesthesia-induced detrusor blockade. Excess diuresis may cause bladder distension and neccecitates bladder catheterization

Objective of the study:

To compare the quantitative effects of Ringer Lactate and HES 6% on diuresis during spinal anesthesia-induced detrusor blockade as well as prevention of hypotension and vasopressor use.

Study design:

Before spinal anesthesia is performed, patients are randomized into one of the 3 study groups (no preload, preload with Ringers' Lactate 14 ml/kg, preload with HES 6% 7 ml/kg). Spinal anesthesia is administerd with lidocaine 2% 70mg. Hypotension is treated with vasopressors, atropine or additional intravenous fluid. Bladder scans will be performed on the recovery unit and day-case unit. Total urinary volume is measured until sensory function at dermatome S2/3 is restored and spontanous voiding is possible.

Study population:

ASA 1-2 patients who present for spinal anesthesia for minor surgery on the lower extremitiy. Age 18-60 years.

Intervention (if applicable):

Prespinal administration of intravenous Ringers' Lactate 14 ml/kg or HES 6% 7 ml/kg.

Primary study parameters/outcome of the study:

Primary outcome is total urinary volume during spinal induced detrusor blockade, and number of subjects that have a bladdder volume over 500ml.

Secundary study parameters/outcome of the study (if applicable):

Secondary outcome parameters:

Periods of hypertension, and total dose of vasopressor en extra fluid administration.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness (if applicable):

Except for extra bladderscan and block height measurements, all actions are part of routine anesthesiologic care.

Ga naar boven

02

Conditions studied

  • Diuresis
  • Bladder Retention Volume
  • Hypotension

Keywords

  • spinal anesthesia
  • preload
  • diuresis
  • bladder retention
03

In context

Urinary Retention

235 studies on the registry are indexed under Urinary Retention; 39 are open to participants now.

This study's enrollment of 144 is above the median of 95 across 185 interventional studies indexed under Urinary Retention.

Browse Urinary Retention studies →

Lead sponsor

Rijnstate Hospital is the lead sponsor of 127 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA1-2
  • undergoing minor procedure under spinal anesthesia

Exclusion criteria

Exclusion Criteria:

  • ASA3-4
  • History or signs of heart failure / coronary artery disease.
  • Bladder / urinary disease
  • Neurologic disease that may affect bladder function
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
144 participants (actual)

Study arms

  • Placebo comparator
    1

    No preload

    Other: placebo

  • Active comparator
    2

    Preload with cristalloid infusion

    Drug: Ringers Lactate

  • Active comparator
    3

    Preload with collid infusion

    Drug: HaemoHES 6%

Interventions

  • Otherplacebo
  • DrugRingers Lactate
  • DrugHaemoHES 6%
06

Study locations

1 site
  • Ziekenhuis Zevenaar
    Zevenaar, Gelderland, Netherlands
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 28, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00550186
Lead sponsor
Rijnstate Hospital
First posted
Oct 29, 2007
Start date
Oct 2007
Primary completion
Dec 2007
Last update
Jun 28, 2016

Study contacts

Marco Peters, MD
principal investigator · Nijmegen University Anesthesiology Department (resident)
Ed Kamphuis, Md, PhD
principal investigator · Rijnstate Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion